HighMark Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8K | Hold |
|
|||||
|
2025
Q2 | $7.16K | Buy |
|
|||||
|
2025
Q1 | $4.31K | Hold |
|
|||||
|
2024
Q4 | $5.32K | Buy |
|
|||||
|
2024
Q3 | $2.88K | Sell |
|
|||||
|
2024
Q2 | $5.51K | Sell |
|
|||||
|
2024
Q1 | $8.28K | Buy |
|
|||||
|
2023
Q4 | $7.51K | Hold |
|
|||||
|
2023
Q3 | $6.41K | Hold |
|
|||||
|
2023
Q2 | $5.38K | Buy |
|
|||||
|
2023
Q1 | $5.57K | Hold |
|
|||||
|
2022
Q4 | $6.57K | Sell |
|
|||||
|
2022
Q3 | $6K | Hold |
|
|||||
|
2022
Q2 | $6K | Sell |
|
|||||
|
2022
Q1 | $6K | Hold |
|
|||||
|
2021
Q4 | $6K | Hold |
|
|||||
|
2021
Q3 | $6K | Sell |
|
|||||
|
2021
Q2 | $7K | Sell |
|
|||||
|
2021
Q1 | $8K | Buy |
|
|||||
|
2020
Q4 | $3K | Buy |
|